Drolet D W, Moon-McDermott L, Romig T S
NeXstar Pharmaceuticals, Boulder, CO 80301, USA.
Nat Biotechnol. 1996 Aug;14(8):1021-5. doi: 10.1038/nbt0896-1021.
The recent development of in vitro methods to select high-affinity ligands by combinatorial chemistry methodologies promises unique and theoretically unlimited supplies of novel therapeutic and diagnostic reagents. One such combinatorial chemistry process, systematic evolution of ligands by exponential enrichment (SELEX), allows rapid identification, from large random sequence pools, of the few oligonucleotide sequences that bind to a desired target molecule with high affinity and specificity. We describe an enzyme-linked sandwich assay that uses a SELEX-derived oligonucleotide. This assay demonstrates that these oligonucleotides can be effective and useful analytical reagents.
最近通过组合化学方法选择高亲和力配体的体外方法的发展,有望提供独特且理论上无限供应的新型治疗和诊断试剂。一种这样的组合化学过程,即指数富集配体系统进化(SELEX),允许从大量随机序列库中快速鉴定出少数与所需靶分子具有高亲和力和特异性结合的寡核苷酸序列。我们描述了一种使用SELEX衍生寡核苷酸的酶联夹心测定法。该测定法表明这些寡核苷酸可以是有效的分析试剂。